Literature DB >> 1797556

Inhibition of [3H]dopamine uptake by flunarizine.

P Devoto1, L Pani, A Kuzmin, G De Montis.   

Abstract

The effect of different calcium channel blockers was studied on basal and cocaine-inhibited [3H]dopamine uptake in rat striatal synaptosomes. Isradipine (dihydropyridine calcium antagonist) and diltiazem (L-type calcium antagonist) were devoid of effect on [3H]dopamine uptake, while flunarizine (T-type calcium antagonist) inhibited [3H]dopamine uptake. Flunarizine inhibition was competitive and the inhibitory curve was biphasic with a Hill coefficient of 2.1. The high Hill number suggested a mechanism of positive cooperativity between two sites. Flunarizine inhibition showed a complex interaction with cocaine inhibition. While flunarizine at low concentrations interacts with a distinct site, at higher concentrations it interacts with the same site as cocaine. The relevance of this finding for the potentiation by flunarizine of cocaine-induced dopamine release in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1797556     DOI: 10.1016/0014-2999(91)90791-n

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice.

Authors:  M Gasior; R Kamiński; T Brudniak; Z Kleinrok; S J Czuczwar
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Potent, extra-channel influence of several calcium-channel modulators on striatal binding of [3H]tyramine.

Authors:  A Vaccari; P Saba; G Gessa
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

3.  Dopaminergic function in rat brain after oral administration of calcium-channel blockers or haloperidol. A microdialysis study.

Authors:  J Reiriz; S Ambrosio; A Cobos; M Ballarín; E Tolosa; N Mahy
Journal:  J Neural Transm Gen Sect       Date:  1994
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.